Clinimetrics of Meniere's disease

Laryngoscope

Volumn 110, Issue 3 III, 2000, Pages 8-11

  Gates, George A ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CLINICAL OBSERVATION; DISEASE SEVERITY; HEALTH STATUS; HUMAN; MENIERE DISEASE; MORBIDITY; OUTCOMES RESEARCH; PRIORITY JOURNAL; RISK ASSESSMENT; VALIDATION PROCESS; VERTIGO;

EID: 0034014339     PISSN: 0023852X     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005537-200003002-00003     Document Type: Article

References (5)

1. Wladislavosky WP, Facer GW, Mokri B, Kurland LT. Meniere's disease: a 30-year epidemiologic and clinical study in Rochester, Mn, 1951-1980. Laryngoscope 1984;94: 1098-1102.
2. Gulya AJ, Schuknecht HF. Classification of endolymphatic hydrops. Am J Otolaryngol 1982;3:319-322.
3. Committee on Hearing and Equilibrium guidelines for the diagnosis and evaluation of therapy in Meniere's disease. American Academy of Otolaryngology - Head and Neck Foundation, Inc. Otolaryngol Head Neck Surg 1995;113: 181-185.
4. Thomsen J, Bretlau P, Tos M, Johnsen NJ. Placebo effect in surgery for Meniere's disease. A double-blind, placebo-controlled study on endolymphatic sac shunt surgery. Arch Otolaryngol 1981;107:271-277.
5. Murphy MP, Gates GA. Measuring the effecting of Meniere's disease: results of the Patient-Oriented Severity Index. Ann Otol Rhinol Laryngol 1999;108:331-337.